TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02606812 — Predictive Biomarker (PRD): miR-145
Genes: MIR145
Study NCT02606812 — Safety Biomarker (SAF): miR-335
Genes: MIR335
Study NCT02606812 — Safety Biomarker (SAF): miR-124a
Study NCT00110526 — Safety Biomarker (SAF): Interleukin 12
Study NCT03603379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03603379 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02301455 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03318731 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02092467 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02472028 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00173693 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02768714 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT01857271 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01612013 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03272061 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT00684489 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00619112 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00729248 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT00433836 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00879216 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02969681 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04425135 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02327845 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01895491 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02067468 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04311372 — Predictive Biomarker (PRD): REST mRNA
Genes: REST; NRSF; XBR
Study NCT00625898 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04111055 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04227847 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT03799926 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00829803 — Predictive Biomarker (PRD): SNAP25 mRNA
Genes: SNAP25; SNAP
Study NCT03760003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02728245 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02303041 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00151125 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00151125 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT04536532 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00479024 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT04186156 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT01341782 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02293889 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02907606 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04514068 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01344564 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02008864 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03213717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04405167 — Predictive Biomarker (PRD): Calgranulin B
Genes: S100A9; CAGB; CFAG; MRP14
Study NCT01235832 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02013479 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT00505921 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT03609736 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05278728 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05278728 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02592083 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04307576 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04307576 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02497651 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04203563 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03712215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02261012 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT03236428 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02292316 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06484725 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04062474 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01162746 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01162746 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01510548 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01546376 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03530696 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00484510 — Pharmacodynamic Biomarker (PDY): Peripheral myelin protein 22
Genes: PMP22; GAS3
Study NCT04524156 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04524156 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01008982 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study NCT03617757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02305979 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01473524 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT04429438 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04641806 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04641806 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01560117 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT00300729 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00522665 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00929890 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01375153 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00399880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00764218 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04443348 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04443348 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00057421 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02460367 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01969890 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04669847 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03333590 — Predictive Biomarker (PRD): B4GALNT2 mRNA
Genes: B4GALNT2; GALGT2
Study NCT03333590 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02374489 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT02374489 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00480766 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01234857 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03489616 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00154271 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00193219 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00193219 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01328665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01508000 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01508000 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT00749021 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03410316 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03514953 — Safety Biomarker (SAF): Interleukin 1
Study NCT00501046 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01351636 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03581591 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT03335176 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03335176 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03335176 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01552486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04627142 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05242211 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00914914 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT00062543 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05108519 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00993486 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00000498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01085058 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03851575 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01248494 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01248494 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01715285 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02315196 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02315196 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00001906 — Safety Biomarker (SAF): Interleukin 12
Study NCT03210714 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT03883386 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02359240 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT04184141 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00522834 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01367041 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02515929 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03453801 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03869086 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01118286 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02226757 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02226757 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02162953 — Predictive Biomarker (PRD): BEST1 mRNA
Genes: BEST1; VMD2
Study NCT03401125 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT02839317 — Predictive Biomarker (PRD): IL10RA mRNA
Genes: IL10RA; IL10R
Study NCT00048399 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT01814683 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT03924089 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03924089 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00960427 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03679546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01784952 — Predictive Biomarker (PRD): APOA5 mRNA
Genes: APOA5; RAP3; UNQ411/PRO773
Study NCT02041156 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00085475 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study NCT04271579 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02140411 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02140411 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01679639 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT02078765 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02078765 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04487951 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00384826 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00933764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02640092 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03454178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04408066 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00120653 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01034553 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT04397861 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00146497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00146497 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00005143 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03507023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03814590 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03657732 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00355810 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04293796 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04325035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04325035 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02656511 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03285100 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study NCT03285100 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT01234922 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01234922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05786183 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT00653718 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01348412 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01348412 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04699851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05395455 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04432480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01474343 — Predictive Biomarker (PRD): SGSH mRNA
Genes: SGSH; HSS
Study NCT01474343 — Predictive Biomarker (PRD): SUMF1 mRNA
Genes: SUMF1; PSEC0152; UNQ3037/PRO9852
Study NCT00495469 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03755323 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01911234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00330525 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01236313 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00863122 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT04205578 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT02652312 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05552170 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT01461512 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01566370 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT01566370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04370860 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02755155 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02212327 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00313339 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01344278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00635232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02188186 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03678285 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03678285 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04045366 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00197652 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00822718 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT00822718 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT01104649 — Predictive Biomarker (PRD): DCN mRNA
Genes: DCN; SLRR1B
Study NCT01104649 — Predictive Biomarker (PRD): KCNN1 mRNA
Genes: KCNN1; SK
Study NCT03247192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03247192 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT02445976 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT01879748 — Predictive Biomarker (PRD): MAOB mRNA
Genes: MAOB
Study NCT01766882 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04675619 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00554606 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04084704 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03083756 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03083756 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT01906450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00488592 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT00488592 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01110135 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT02623296 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02623296 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02623296 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT01200992 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT02212379 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT01782300 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03194841 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03521739 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00054665 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02389712 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT03214029 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT01333891 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01333891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02898753 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT01327768 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT00403884 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT06021574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03401788 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT02991807 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00459017 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01840852 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02677714 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04265001 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02930967 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02930967 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01556360 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03109561 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE